86 related articles for article (PubMed ID: 16532491)
1. The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice.
Martin JL; Jia G; Martin SS; Shapiro TA; Herrmann HC; Dibattiste PM; Topol EJ; Moliterno DJ
Catheter Cardiovasc Interv; 2006 Apr; 67(4):563-70. PubMed ID: 16532491
[TBL] [Abstract][Full Text] [Related]
2. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Nie B; Ge HL; Jia DA; Yang SW; Yan ZX
Heart; 2009 Oct; 95(19):1587-92. PubMed ID: 19592387
[TBL] [Abstract][Full Text] [Related]
3. The relationship of body mass index to outcomes after percutaneous coronary intervention.
Shubair MM; Prabhakaran P; Pavlova V; Velianou JL; Sharma AM; Natarajan MK
J Interv Cardiol; 2006 Oct; 19(5):388-95. PubMed ID: 17020562
[TBL] [Abstract][Full Text] [Related]
4. Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents.
Sarno G; Räber L; Onuma Y; Garg S; Brugaletta S; van Domburg RT; Pilgrim T; Pfäffli N; Wenaweser P; Windecker S; Serruys P
Am J Cardiol; 2011 Jul; 108(2):195-201. PubMed ID: 21529741
[TBL] [Abstract][Full Text] [Related]
5. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction.
Nikolsky E; Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Negoita M; Lansky AJ; Mehran R
Am Heart J; 2006 Jan; 151(1):168-75. PubMed ID: 16368312
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
[TBL] [Abstract][Full Text] [Related]
7. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
8. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM
J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577
[TBL] [Abstract][Full Text] [Related]
9. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
[TBL] [Abstract][Full Text] [Related]
10. [Impact of overweight on clinical outcomes in patients undergoing coronary revascularization].
Kang JP; Ma CS; Lü Q; Nie SP; Liu XM; Liu XH; DU X; Hu R; Dong JZ; Chen F; Lü SZ; Gu CX; Huang FJ; Wu XS
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1381-4. PubMed ID: 20646625
[TBL] [Abstract][Full Text] [Related]
11. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting.
Kandzari DE; Tuttle RH; Zidar JP; Jollis JG
Am J Cardiol; 2006 May; 97(10):1467-72. PubMed ID: 16679085
[TBL] [Abstract][Full Text] [Related]
14. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
[TBL] [Abstract][Full Text] [Related]
15. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death.
Nigam A; Wright RS; Allison TG; Williams BA; Kopecky SL; Reeder GS; Murphy JG; Jaffe AS
Int J Cardiol; 2006 Jun; 110(2):153-9. PubMed ID: 16043245
[TBL] [Abstract][Full Text] [Related]
16. Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?
Gruberg L; Mercado N; Milo S; Boersma E; Disco C; van Es GA; Lemos PA; Ben Tzvi M; Wijns W; Unger F; Beyar R; Serruys PW;
Am J Cardiol; 2005 Feb; 95(4):439-44. PubMed ID: 15695125
[TBL] [Abstract][Full Text] [Related]
17. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes.
Eisenstein EL; McGuire DK; Bhapkar MV; Kristinsson A; Hochman JS; Kong DF; Califf RM; Van de Werf F; Yancy WS; Newby LK
Am J Med; 2005 Sep; 118(9):981-90. PubMed ID: 16164884
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
[TBL] [Abstract][Full Text] [Related]
19. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry).
Byrne J; Spence MS; Fretz E; Mildenberger R; Chase A; Berry B; Pi D; Janssen C; Klinke P; Hilton D
Am J Cardiol; 2009 Feb; 103(4):507-11. PubMed ID: 19195511
[TBL] [Abstract][Full Text] [Related]
20. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
